These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 24105826)

  • 1. Drugs associated with teratogenic mechanisms. Part I: dispensing rates among pregnant women in the Netherlands, 1998-2009.
    van Gelder MM; Bos JH; Roeleveld N; de Jong-van den Berg LT
    Hum Reprod; 2014 Jan; 29(1):161-7. PubMed ID: 24105826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drugs associated with teratogenic mechanisms. Part II: a literature review of the evidence on human risks.
    van Gelder MM; de Jong-van den Berg LT; Roeleveld N
    Hum Reprod; 2014 Jan; 29(1):168-83. PubMed ID: 24108217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-Risk Medication Prescriptions in Primary Care for Women Without Documented Contraception.
    Panchal BD; Cash R; Moreno C; Vrontos E; Bourne C; Palmer S; Simpson A; Panchal AR
    J Am Board Fam Med; 2019; 32(4):474-480. PubMed ID: 31300567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isotretinoin use and compliance with the Dutch Pregnancy Prevention Programme: a retrospective cohort study in females of reproductive age using pharmacy dispensing data.
    Teichert M; Visser LE; Dufour M; Rodenburg E; Straus SM; De Smet PA; Stricker BH
    Drug Saf; 2010 Apr; 33(4):315-26. PubMed ID: 20297863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dispensing patterns and pregnancy outcomes for women dispensed selective serotonin reuptake inhibitors in pregnancy.
    Colvin L; Slack-Smith L; Stanley FJ; Bower C
    Birth Defects Res A Clin Mol Teratol; 2011 Mar; 91(3):142-52. PubMed ID: 21381184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trends in prescription drug use during pregnancy and postpartum in Norway, 2005 to 2015.
    Engeland A; Bjørge T; Klungsøyr K; Hjellvik V; Skurtveit S; Furu K
    Pharmacoepidemiol Drug Saf; 2018 Sep; 27(9):995-1004. PubMed ID: 29920833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug prescribing before and during pregnancy in south west France: a retrolective study.
    Crespin S; Bourrel R; Hurault-Delarue C; Lapeyre-Mestre M; Montastruc JL; Damase-Michel C
    Drug Saf; 2011 Jul; 34(7):595-604. PubMed ID: 21663335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dispensing of potentially teratogenic drugs before conception and during pregnancy: a population-based study.
    Zomerdijk IM; Ruiter R; Houweling LM; Herings RM; Straus SM; Stricker BH
    BJOG; 2015 Jul; 122(8):1119-29. PubMed ID: 25316196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concurrent use of hormonal long-acting reversible contraception by women of reproductive age dispensed teratogenic medications, Australia, 2013-2021: a retrospective cohort study.
    Grzeskowiak LE; Moore V; Hall K; Ilomäki J; Schoenaker D; Lovegrove E; Mazza D; Black KI; Kennedy DS; Davies MJ; Rumbold A
    Med J Aust; 2024 Oct; 221(7):367-373. PubMed ID: 39285147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prenatal exposure to teratogenic medications in the era of Risk Evaluation and Mitigation Strategies.
    Sarayani A; Albogami Y; Thai TN; Smolinski NE; Patel P; Wang Y; Nduaguba S; Rasmussen SA; Winterstein AG
    Am J Obstet Gynecol; 2022 Aug; 227(2):263.e1-263.e38. PubMed ID: 35032444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Provision of potentially teratogenic medications to female veterans of childbearing age.
    Schwarz EB; Longo LS; Zhao X; Stone RA; Cunningham F; Good CB
    Med Care; 2010 Sep; 48(9):834-42. PubMed ID: 20706159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increase in use of selective serotonin reuptake inhibitors in pregnancy during the last decade, a population-based cohort study from the Netherlands.
    Bakker MK; Kölling P; van den Berg PB; de Walle HE; de Jong van den Berg LT
    Br J Clin Pharmacol; 2008 Apr; 65(4):600-6. PubMed ID: 17953715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Counseling about medication-induced birth defects with clinical decision support in primary care.
    Schwarz EB; Parisi SM; Handler SM; Koren G; Shevchik G; Fischer GS
    J Womens Health (Larchmt); 2013 Oct; 22(10):817-24. PubMed ID: 23930947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug-prescribing patterns during pregnancy in the tertiary care hospitals of Pakistan: a cross sectional study.
    Rohra DK; Das N; Azam SI; Solangi NA; Memon Z; Shaikh AM; Khan NH
    BMC Pregnancy Childbirth; 2008 Jul; 8():24. PubMed ID: 18627607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identifying associations between maternal medication use and birth defects using a case-population approach: an exploratory study on signal detection.
    de Jonge L; Zetstra-van der Woude PA; Bos HJ; de Jong-van den Berg LT; Bakker MK
    Drug Saf; 2013 Nov; 36(11):1069-78. PubMed ID: 23828658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug prescription patterns before, during and after pregnancy for chronic, occasional and pregnancy-related drugs in the Netherlands.
    Bakker MK; Jentink J; Vroom F; Van Den Berg PB; De Walle HE; De Jong-Van Den Berg LT
    BJOG; 2006 May; 113(5):559-68. PubMed ID: 16637899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prescription medicines with potential for foetal harm: dispensing before and during pregnancy in New Zealand, 2005-2015.
    Donald S; Sharples K; Barson D; Horsburgh S; Parkin L
    Eur J Clin Pharmacol; 2020 Jun; 76(6):887-896. PubMed ID: 32248249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physicians' Perception of Teratogenic Risk and Confidence in Prescribing Drugs in Pregnancy-Influence of Norwegian Drug Information Centers.
    Bakkebø T; Widnes SF; Aamlid SS; Schjøtt J
    Clin Ther; 2016 May; 38(5):1102-8. PubMed ID: 26973297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Documentation of contraception and pregnancy when prescribing potentially teratogenic medications for reproductive-age women.
    Schwarz EB; Postlethwaite DA; Hung YY; Armstrong MA
    Ann Intern Med; 2007 Sep; 147(6):370-6. PubMed ID: 17876020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Periconceptional exposure to lopinavir, but not darunavir, impairs decidualization: a potential mechanism leading to poor birth outcomes in HIV-positive pregnancies.
    Kala S; Dunk C; Acosta S; Serghides L
    Hum Reprod; 2020 Aug; 35(8):1781-1796. PubMed ID: 32712670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.